Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription


3 Clin Infect Dis
1 J Infect
4 J Infect Dis
3 Lancet
1 MMWR Morb Mortal Wkly Rep
9 N Engl J Med
1 Nat Med
2 Pediatr Infect Dis J
1 Pediatr Rev
1 Pediatrics
1 PLoS Med
2 PLoS One
1 Proc Natl Acad Sci U S A
1 Science
15 Vaccine
1 Virus Res

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles


  1. DOSHI P
    Covid-19: Spreading vaccine "misinformation" puts licence at risk, US boards tell physicians.
    BMJ. 2021;375:n2417.

  2. PAVORD S, Hunt BJ, Horner D, Bewley S, et al
    Vaccine induced immune thrombocytopenia and thrombosis: summary of NICE guidance.
    BMJ. 2021;375:n2195.

  3. WISE J
    Vaccinating against covid and flu at same time is safe, study shows.
    BMJ. 2021;375:n2411.

    Covid-19: Why the Balkans' vaccine rollout lags behind most of Europe.
    BMJ. 2021;375:n2412.

    Covid-19: Vaccine advisory committee must be more transparent about decisions, say researchers.
    BMJ. 2021;375:n2452.

  6. WISE J
    WHO hails "historic day" as it recommends malaria vaccine.
    BMJ. 2021;375:n2455.

    Clin Infect Dis

  7. RIVERA L, Biswal S, Saez-Llorens X, Reynales H, et al
    Three years efficacy and safety of Takeda's dengue vaccine candidate (TAK-003).
    Clin Infect Dis. 2021 Oct 4. pii: 6381105. doi: 10.1093.
    PubMed         Abstract available

  8. MAZUR NI, Lowensteyn YN, Willemsen JE, Gill CJ, et al
    Global Respiratory Syncytial Virus-Related Infant Community Deaths.
    Clin Infect Dis. 2021;73.
    PubMed         Abstract available

  9. SRIKANTIAH P, Vora P, Klugman KP
    Assessing the Full Burden of Respiratory Syncytial Virus in Young Infants in Low- and Middle-Income Countries: The Importance of Community Mortality Studies.
    Clin Infect Dis. 2021;73.
    PubMed         Abstract available

    J Infect

  10. FERRE VM, Lebourgeois S, Menidjel R, Collin G, et al
    Decreasing humoral response among healthcare workers up to 4 months after two doses of BNT162b2 vaccine.
    J Infect. 2021 Sep 29. pii: S0163-4453(21)00488.

    J Infect Dis

  11. CARRYN S, Cheuvart B, Povey M, Dagnew AF, et al
    No consistent evidence of decreased exposure to varicella-zoster virus among older adults in countries with universal varicella vaccination.
    J Infect Dis. 2021 Oct 5. pii: 6381619. doi: 10.1093.
    PubMed         Abstract available

  12. GERSHON AA, Gershon MD
    Widespread use of varicella vaccine does not reduce immunity to zoster of others.
    J Infect Dis. 2021 Oct 5. pii: 6381628. doi: 10.1093.

  13. LU Y, Jiao Y, Graham DJ, Wu Y, et al
    Risk factors for COVID-19 deaths among elderly nursing home Medicare beneficiaries in the pre-vaccine period.
    J Infect Dis. 2021 Oct 7. pii: 6383455. doi: 10.1093.
    PubMed         Abstract available

  14. GAST C, Bandyopadhyay AS, Saez-Llorens X, De Leon T, et al
    Fecal shedding of two novel live attenuated oral poliovirus type 2 vaccines candidates by healthy bOPV/IPV-vaccinated infants: two randomized clinical trials.
    J Infect Dis. 2021 Oct 5. pii: 6381642. doi: 10.1093.
    PubMed         Abstract available


  15. WOO EJ, Mba-Jonas A, Dimova RB, Alimchandani M, et al
    Association of Receipt of the Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barre Syndrome, February-July 2021.
    JAMA. 2021 Oct 7. pii: 2785009. doi: 10.1001/jama.2021.16496.
    PubMed         Abstract available

  16. DETSKY AS, Bogoch II
    COVID-19 in Canada: Experience and Response to Waves 2 and 3.
    JAMA. 2021 Aug 23. pii: 2783610. doi: 10.1001/jama.2021.14797.


  17. PRENDECKI M, Thomson T, Clarke CL, Martin P, et al
    Immunological responses to SARS-CoV-2 vaccines in kidney transplant recipients.
    Lancet. 2021 Oct 4. pii: S0140-6736(21)02096.

  18. TARTOF SY, Slezak JM, Fischer H, Hong V, et al
    Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study.
    Lancet. 2021 Oct 4. pii: S0140-6736(21)02183.
    PubMed         Abstract available

    COVID-19: learning as an interdependent world.
    Lancet. 2021;398:1105.

    MMWR Morb Mortal Wkly Rep

  20. VAN NAARDEN BRAUN K, Drexler M, Rozenfeld RA, Deener-Agus E, et al
    Multicomponent Strategies to Prevent SARS-CoV-2 Transmission - Nine Overnight Youth Summer Camps, United States, June-August 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1420-1424.
    PubMed         Abstract available

    N Engl J Med

  21. THOMPSON MG, Grant L, Meece J
    Prevention of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines. Reply.
    N Engl J Med. 2021 Oct 6. pii: 10.1056/NEJMc2113575.

  22. ZHANG C, Yin G
    Prevention of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.
    N Engl J Med. 2021 Oct 6. pii: 10.1056/NEJMc2113575.

    Prevention of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.
    N Engl J Med. 2021 Oct 6. pii: 10.1056/NEJMc2113575.

  24. SANTACATTERINA M, Sanders JW, Weintraub WS
    Prevention of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.
    N Engl J Med. 2021 Oct 6. pii: 10.1056/NEJMc2113575.

  25. LEVIN EG, Lustig Y, Cohen C, Fluss R, et al
    Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months.
    N Engl J Med. 2021 Oct 6. doi: 10.1056/NEJMoa2114583.
    PubMed         Abstract available

  26. CHEMAITELLY H, Tang P, Hasan MR, AlMukdad S, et al
    Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar.
    N Engl J Med. 2021 Oct 6. doi: 10.1056/NEJMoa2114114.
    PubMed         Abstract available

  27. MEVORACH D, Anis E, Cedar N, Bromberg M, et al
    Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel.
    N Engl J Med. 2021 Oct 6. doi: 10.1056/NEJMoa2109730.
    PubMed         Abstract available

  28. WITBERG G, Barda N, Hoss S, Richter I, et al
    Myocarditis after Covid-19 Vaccination in a Large Health Care Organization.
    N Engl J Med. 2021 Oct 6. doi: 10.1056/NEJMoa2110737.
    PubMed         Abstract available

  29. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Are Covid-19 Vaccine Boosters Necessary?
    N Engl J Med. 2021;385:e63.

    Nat Med

  30. ALI M, Khan J, Ahmad N, Khan H, et al
    COVID-19 vaccination gives hope to eradicate polio.
    Nat Med. 2021 Oct 4. pii: 10.1038/s41591-021-01518.

    Pediatr Infect Dis J

  31. HERINI ES, Triono A, Iskandar K, Prasetyo A, et al
    Congenital Rubella Syndrome Surveillance After Measles Rubella Vaccination Introduction in Yogyakarta, Indonesia.
    Pediatr Infect Dis J. 2021 Sep 7. pii: 00006454-900000000-95683.
    PubMed         Abstract available

  32. REGALADO L D, Rivera-Olivero IA, Garcia-Bereguiain MA, Tana L, et al
    Pneumococcal Carriage Among Indigenous Kichwa Children From the Ecuadorian Andes After the 10-Valent Pneumococcal Vaccine Introduction.
    Pediatr Infect Dis J. 2021 Sep 7. pii: 00006454-900000000-95691.
    PubMed         Abstract available

    Pediatr Rev

  33. MOORTHY GS, Smith MJ, Staples BB
    Coronavirus Disease 2019 Vaccine in Children.
    Pediatr Rev. 2021;42:576-578.


  34. DESANTE-BERTKAU JE, Knilans TK, Persad G, Zettler PJ, et al
    Off-Label Prescription of COVID-19 Vaccines in Children: Clinical, Ethical, and Legal Issues.
    Pediatrics. 2021 Oct 6. pii: peds.2021-054578. doi: 10.1542/peds.2021-054578.

    PLoS Med

  35. PEARSON CAB, Bozzani F, Procter SR, Davies NG, et al
    COVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectiveness.
    PLoS Med. 2021;18:e1003815.
    PubMed         Abstract available

    PLoS One

  36. MURAYAMA T, Shimizu N, Fujita S, Wakamiya S, et al
    Predicting regional influenza epidemics with uncertainty estimation using commuting data in Japan.
    PLoS One. 2021;16:e0250417.
    PubMed         Abstract available

  37. BACHELET T, Bourdenx JP, Martinez C, Mucha S, et al
    Humoral response after SARS-CoV-2 mRNA vaccines in dialysis patients: Integrating anti-SARS-CoV-2 Spike-Protein-RBD antibody monitoring to manage dialysis centers in pandemic times.
    PLoS One. 2021;16:e0257646.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  38. HENSEN L, Nguyen THO, Rowntree LC, Damelang T, et al
    Robust and prototypical immune responses toward influenza vaccines in the high-risk group of Indigenous Australians.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available


  39. CAMPOS-MERCADE P, Meier AN, Schneider FH, Meier S, et al
    Monetary incentives increase COVID-19 vaccinations.
    Science. 2021 Oct 7:eabm0475. doi: 10.1126/science.abm0475.
    PubMed         Abstract available


  40. MCNAY LA, Arnoczy G, Martell M, Mock P, et al
    Community-based hospitals: New partners for government-sponsored clinical research during public health emergencies.
    Vaccine. 2021;39:6183-6185.
    PubMed         Abstract available

  41. HOFMEISTER MG, Weng MK, Thoroughman D, Thomasson ED, et al
    Prevalence of indications for adult hepatitis A vaccination among hepatitis A outbreak-associated cases, Three US States, 2016-2019.
    Vaccine. 2021 Sep 28. pii: S0264-410X(21)01254.
    PubMed         Abstract available

  42. ROMANO CJ, Hall C, Khodr ZG, Bukowinski AT, et al
    History of pandemic H1N1-containing influenza vaccination and risk for spontaneous abortion and birth defects.
    Vaccine. 2021 Sep 28. pii: S0264-410X(21)01171.
    PubMed         Abstract available

  43. YACOUB MR, Cucca V, Asperti C, Ramirez GA, et al
    Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine.
    Vaccine. 2021 Sep 28. pii: S0264-410X(21)01239.
    PubMed         Abstract available

  44. SHEVZOV-ZEBRUN N, Caplan A
    Parental consent for vaccination of minors against COVID-19.
    Vaccine. 2021 Sep 25. pii: S0264-410X(21)01250.

  45. FRANCIS-OLIVIERO F, Bozoki S, Micsik A, Kieny MP, et al
    Research priorities to increase vaccination coverage in Europe (EU joint action on vaccination).
    Vaccine. 2021 Sep 28. pii: S0264-410X(21)01224.
    PubMed         Abstract available

  46. SINGH AK, Phatak SR, Singh R, Bhattacharjee K, et al
    Antibody response after first and second-dose of ChAdOx1-nCOV (Covishield(TM)(R)) and BBV-152 (Covaxin(TM)(R)) among health care workers in India: The final results of cross-sectional coronavirus vaccine-induced antibody titre (COVAT) study.
    Vaccine. 2021 Sep 24. pii: S0264-410X(21)01258.
    PubMed         Abstract available

  47. FADLYANA E, Rusmil K, Tarigan R, Rahmadi AR, et al
    A phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-CoV-2 inactivated vaccine in healthy adults aged 18-59 years: An interim analysis in Indonesia.
    Vaccine. 2021 Sep 24. pii: S0264-410X(21)01255.
    PubMed         Abstract available

  48. SRICHAN P, Thohinung U, Kodyee S, Apidechkul T, et al
    Vaccine serocoverage under the expanded program on immunization among hill tribe children in Thailand: A cross-sectional study.
    Vaccine. 2021 Oct 1. pii: S0264-410X(21)01264.
    PubMed         Abstract available

  49. MOORE KA, Ostrowsky JT, Kraigsley AM, Mehr AJ, et al
    A Research and Development (R&D) roadmap for influenza vaccines: Looking toward the future.
    Vaccine. 2021 Sep 23. pii: S0264-410X(21)01028.
    PubMed         Abstract available

  50. KHAIMOVA R, Fischetti B, Cope R, Berkowitz L, et al
    Serological response with Heplisav-B(R) in prior Hepatitis B vaccine non-responders living with HIV.
    Vaccine. 2021 Sep 29. pii: S0264-410X(21)01251.
    PubMed         Abstract available

  51. NIEUWENHUIZEN NE, Zyla J, Zedler U, Bandermann S, et al
    Weaker protection against tuberculosis in BCG-vaccinated male 129 S2 mice compared to females.
    Vaccine. 2021 Sep 30. pii: S0264-410X(21)01230.
    PubMed         Abstract available

  52. LEWIS G, Lazzaro T, Crawford NW
    Recurrent lipoatrophy following multiple vaccinations: A case study.
    Vaccine. 2021 Sep 30. pii: S0264-410X(21)01237.

  53. VIEIRA REZENDE RP, Braz AS, Guimaraes MFB, Ribeiro SLE, et al
    Characteristics associated with COVID-19 vaccine hesitancy: A nationwide survey of 1000 patients with immune-mediated inflammatory diseases.
    Vaccine. 2021 Sep 25. pii: S0264-410X(21)01260.
    PubMed         Abstract available

  54. BLEICHER I, Kadour-Peero E, Sagi-Dain L, Sagi S, et al
    Early exploration of COVID-19 vaccination safety and effectiveness during pregnancy: interim descriptive data from a prospective observational study.
    Vaccine. 2021 Sep 25. pii: S0264-410X(21)01234.
    PubMed         Abstract available

    Virus Res

  55. ANWAR MN, Guo S, Xin W, Hameed M, et al
    Adaptation of a live-attenuated genotype I Japanese encephalitis virus to vero cells is associated with mutations in structural protein genes.
    Virus Res. 2021;292:198256.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.